ATL2 p.Pro548Ser
c.1642C>T · rs781044136 · VCV3131063
Computational evidence
| Protein change | ||
| AlphaMissense | 0.6596 | likely pathogenic |
|---|---|---|
| REVEL | 0.625 | indeterminate |
| SaProt | LLR -9.98 | tolerated |
| ⇒ AlphaMissense calls this damaging; SaProt does not; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 10 | GERP 1.5, phastCons 1 |
| Regional constraint | o/e 1.05 | unconstrained · MANE · 81 kb · p 0.18 · regional, not allelic |
| Overall | ||
| CADD | 25.1 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 0.0417% | 2,397 |
| Remaining individualsnot grpmax-eligible | 0.00333% | 30,040 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ATL2
- Protein
- p.Pro548Ser
- Coding
- c.1642C>T
- MANE Select
- NM_001135673
- dbSNP
- rs781044136
- Type
- single nucleotide variant
- Location
- chr2:38296104 (GRCh38)
- Gene constraint
- LOEUF 0.647 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 84.36
- Residue 548
- the 'autoinhibitory domain' region
Similar variants
- ATL2 p.Gly365= Benign ★★ same type
- ATL2 p.Ala100Val Uncertain significance ★ ⚠ same type
- ATL2 p.Ala227Gly Uncertain significance ★ ⚠ same type
- ATL2 p.Ala28Gly Uncertain significance ★ ⚠ same type
- ATL2 p.Ala2Val Uncertain significance ★ ⚠ same type
- ATL2 p.Ala388Ser Uncertain significance ★ ⚠ same type
- ATL2 p.Ala388Val Uncertain significance ★ ⚠ same type
- ATL2 p.Ala425Val Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/atl2-p-pro548ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown